INAT-Farma

INAT-Farma is a biotechnology company based in Belgrade, Serbia, specializing in the development of innovative radiopharmaceuticals for targeted cancer therapy and molecular imaging. The company focuses on the design and synthesis of novel peptide-based ligands and small molecules that target specific receptors overexpressed in various malignancies, such as neuroendocrine tumors and prostate cancer. By leveraging advanced radiochemistry, INAT-Farma aims to provide precision medicine solutions that integrate diagnostics and therapeutics (theranostics). Their pipeline includes several candidates in the pre-clinical stage designed to improve the efficacy and safety of radionuclide therapy.